Selim O - Search Results

1

Response to interferon-alpha of Egyptian patients infected with hepatitis C virus genotype 4.

el-Zayadi A, Simmonds P, Dabbous H, Prescott L, Selim O, Ahdy A. el-Zayadi A, et al. Among authors: selim o. J Viral Hepat. 1996 Sep;3(5):261-4. doi: 10.1111/j.1365-2893.1996.tb00052.x. J Viral Hepat. 1996. PMID: 8914006 Clinical Trial.

2

Impact of cigarette smoking on response to interferon therapy in chronic hepatitis C Egyptian patients.

El-Zayadi A, Selim O, Hamdy H, El-Tawil A, Badran HM, Attia M, Saeed A. El-Zayadi A, et al. Among authors: selim o. World J Gastroenterol. 2004 Oct 15;10(20):2963-6. doi: 10.3748/wjg.v10.i20.2963. World J Gastroenterol. 2004. PMID: 15378774 Free PMC article. Clinical Trial.

3

Prevalence of GBV-C/hepatitis G virus viraemia among blood donors, health care personnel, chronic non-B non-C hepatitis, chronic hepatitis C and hemodialysis patients in Egypt.

El-Zayadi AR, Abe K, Selim O, Naito H, Hess G, Ahdy A. El-Zayadi AR, et al. Among authors: selim o. J Virol Methods. 1999 Jun;80(1):53-8. doi: 10.1016/s0166-0934(99)00036-1. J Virol Methods. 1999. PMID: 10403676

4

Combination treatment of interferon alpha-2b and ribavirin in comparison to interferon monotherapy in treatment of chronic hepatitis C genotype 4 patients.

el-Zayadi A, Selim O, Haddad S, Simmonds P, Hamdy H, Badran HM, Shawky S. el-Zayadi A, et al. Among authors: selim o. Ital J Gastroenterol Hepatol. 1999 Aug-Sep;31(6):472-5. Ital J Gastroenterol Hepatol. 1999. PMID: 10575565 Clinical Trial.

5

Hepatitis C virus genotypes among HCV-chronic liver disease patients in Egypt: a leading trial.

El-Zayadi A, Simmonds P, Dabbous H, Selim O. El-Zayadi A, et al. Among authors: selim o. J Egypt Public Health Assoc. 1994;69(5-6):327-34. J Egypt Public Health Assoc. 1994. PMID: 17212002

6

Controlled trial with interferon alfa 2-b in chronic hepatitis C patients.

El-Zayadi AR, Selim O, El-Haddad S, Ahdy A. El-Zayadi AR, et al. Among authors: selim o. J Egypt Public Health Assoc. 1994;69(5-6):335-45. J Egypt Public Health Assoc. 1994. PMID: 17212003 Clinical Trial.

7

Non-interferon-based therapy: an option for amelioration of necro-inflammation in hepatitis C patients who cannot afford interferon therapy.

El-Zayadi AR, Attia M, Badran HM, El-Tawil A, Zalata K, Barakat E, Selim O, El-Nakeeb A, Saied A. El-Zayadi AR, et al. Among authors: selim o. Liver Int. 2005 Aug;25(4):746-51. doi: 10.1111/j.1478-3231.2005.01110.x. Liver Int. 2005. PMID: 15998425 Clinical Trial.

8

Response of hepatitis C genotype-4 naïve patients to 24 weeks of Peg-interferon-alpha2b/ribavirin or induction-dose interferon-alpha2b/ribavirin/amantadine: a non-randomized controlled study.

El-Zayadi AR, Attia M, Barakat EM, Badran HM, Hamdy H, El-Tawil A, El-Nakeeb A, Selim O, Saied A. El-Zayadi AR, et al. Among authors: selim o. Am J Gastroenterol. 2005 Nov;100(11):2447-52. doi: 10.1111/j.1572-0241.2005.00253.x. Am J Gastroenterol. 2005. PMID: 16279899 Clinical Trial.

9

Association of chronic hepatitis C infection and diabetes mellitus.

el-Zayadi AR, Selim OE, Hamdy H, Dabbous H, Ahdy A, Moniem SA. el-Zayadi AR, et al. Among authors: selim oe. Trop Gastroenterol. 1998 Oct-Dec;19(4):141-4. Trop Gastroenterol. 1998. PMID: 10228436

10

Prevalence of delta antibodies among urban HBsAg-positive chronic liver disease patients in Egypt.

el Zayadi A, Ponzetto A, Selim O, Forzani B, Lavarini C, Rizzetto M. el Zayadi A, et al. Among authors: selim o. Hepatogastroenterology. 1988 Dec;35(6):313-5. Hepatogastroenterology. 1988. PMID: 3265126

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

51 results

Search Page

Filters